Tuberculosis remains a major global health burden, increasingly complicated by rising drug-resistant forms such as MDR and XDR-TB. While conventional diagnostics play a key role, they often fall short in detecting resistance early. Advanced molecular diagnostics, including real-time PCR, point-of-care systems, and targeted NGS are transforming TB diagnosis by enabling faster detection, comprehensive resistance profiling, and more effective, timely treatment decisions. tuberculosis, molecular diagnostics solutions, poct, point of care testing, poc solution, ngs, ngs solutions, rt-pcr, rt-pcr solution, drug resistant, drug resistant tuberculosis, tb solution, tb diagnosis